The RCVS Council has approved a pathway for veterinary and animal health paraprofessionals to become associates of, or accredited by the College and thereby fall within its regulatory remit.

At the June 2017 meeting of RCVS Council, members decided to look into two models by which paraprofessionals working in the veterinary, animal health or related fields, might be regulated by the College under powers granted by the RCVS’s Royal Charter in 2015.

The first was an accreditation model, which would involve the RCVS accrediting an organisation which would regulate the profession in question. The second was an associate/ full regulation model, in which individual paraprofessionals would receive a similar level of regulation to that already received by veterinary surgeons and veterinary nurses.

At its January 2019 meeting, RCVS Council agreed to proceed with both proposed models of paraprofessional regulation, with the suitability of each model being considered on a case-by-case basis, depending on the nature of the profession applying for recognition.

Paraprofessions whose work will need to be underpinned by Schedule 3 reform would need to apply for the associate model, as the RCVS would be required to be directly responsible for the register of any individuals undertaking such minor acts of veterinary surgery.

Two paraprofessional groups that have already expressed an interest in being regulated by the College, namely meat inspectors and animal behaviourists, will now be invited to apply for associate or accredited status.

Eleanor Ferguson, RCVS Registrar, said: "This is a very significant decision by Council to open up a pathway to related paraprofessions to apply to become regulated by the College.

"It is difficult to give a time-frame at this stage as to when these particular professions will be brought on board, as we will have to go through a process of developing a number of new regulatory structures including registration, education and investigation and disciplinary, as well as the appropriate governing bodies for each of the professions.

"However, we are very pleased that the Association of Meat Inspectors (AMI) and the Animal Behaviour and Training Council (ABTC) have expressed an interested in being regulated by the College and we look forward to working with them to make this happen."

David Montgomery, President of the ABTC, said: "The ABTC enthusiastically welcomes the news that the RCVS is expanding its influence to include paraprofessionals. We look forward to exploring the opportunity to demonstrate the professional status of ABTC-registered Animal Trainers and Behaviourists by coming under the regulatory umbrella of the RCVS for the benefit of animal welfare."

Ian Robinson, a Trustee of the AMI, said: "The Association of Meat Inspectors welcome the news that the Royal College of Veterinary Surgeons intends to invite paraprofessionals to be regulated under the ambit of the RCVS. We believe it will offer enhanced security, opportunity and status, and we look forward to further dialogue to explore the various models in due course."

The College says it is also in touch with a number of other paraprofessional groups, including those representing animal musculoskeletal practitioners and equine dental technicians, about the future of paraprofessional regulation. However, before such professions could become associates, there would need to be reform of the Veterinary Surgeons Act in order to remedy some of the deficiencies of the current legislative regime and make sure that these groups have appropriate legal underpinning for their work. This, says the College, complements ongoing discussions on changes to the legislative framework to bolster the role of veterinary nurses. 

On particular issue that the College says the new proposals are designed to remedy is that of equine dental procedures being carried out by well-trained but nevertheless unregulated paraprofessionals. Neil Townsend, Chair of the British Equine Veterinary Association’s (BEVA) Allied Professional Committee, said: "Change to the current situation, where legislative enforcement is impossible, horse owners are confused, and horse welfare is compromised, is long overdue. BEVA is really pleased that the RCVS has listened and is supporting a proposal for regulation of all equine dental procedures. We hope that Government will act."

RCVS President Amanda Boag, said: "This is a real milestone in the history of the RCVS and represents quite possibly the biggest change to our regulatory role since the introduction of the Register of veterinary nurses in 2007, and should Schedule 3 reform be achieved it would be the most significant change since the role of veterinary nurses was first recognised in law in 1991. It is particularly befitting for our 175^th anniversary year, as it demonstrates we are an organisation that can evolve to meet the changes occurring in the wider veterinary and animal health sector and use our regulatory experience and expertise to ensure that animal health and welfare and public health is safeguarded in different, but related fields of endeavour."

The full approved paper regarding the review of the minor procedures regime and paraprofessional regulation can be found on the RCVS website at: https://www.rcvs.org.uk/news-and-views/policy/veterinary-legislation-review/ 

The National Office of Animal Health (NOAH) has published the 2019 edition of its Compendium of Data Sheets for Animal Medicines and updated the accompanying app.

A free copy of the compendium has been sent to every veterinary practice in the UK, and it is also available online at: www.noahcompendium.co.uk. A special edition of the book commissioned by AMTRA will also be available for its SQPs shortly.

NOAH chief executive Dawn Howard said: "The NOAH Compendium, in all its formats, remains a major part of NOAH’s efforts to ensure appropriate access and responsible use of medicines for all animals. We are pleased it is even more comprehensive this year, as we continue to expand its list of contributors.

"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements."

She added: “As well as product datasheets, the Compendium includes another vital resource – the contact details for each participating company. Company veterinary and technical advisors have detailed knowledge about their company’s medicines. The NOAH Code includes the requirement for NCAH qualification for NOAH staff in technical dialogue with prescribers and users of animal medicines – meaning their advice can be regarded as a valuable and trusted resource. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet."

Veterinary practices that have not yet received a copy, perhaps because they are new or have changed address in the past year should contact NOAH (noah@noah.co.uk). 

Extra copies are also available to order, for £47.50. Special prices are also available for bulk orders.

Zoetis reports that its stock of Equip Artervac, its Equine Viral Arteritis (EVA) vaccine, is due to expire on 13th December, and new stocks are not expected before February 2019.

Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.

Zoetis says it is working hard to resolve the situation and apologises for any convenience caused.

For more information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1. 

MSD Animal Health is reminding veterinary surgeons that the deadline to apply for one of its £4000 2018 research bursaries is drawing near.

There are three awards on offer: two ruminant bursaries and one companion animal bursary. Applications must be in by 30th November 2018. 

Each project should be completed within one to two years and the vet practitioner proposals will be judged by university academics to ensure independent assessment.

The companion animal research bursary will be assessed by the University of Nottingham Centre for Evidence-based Veterinary Medicine and the ruminant research bursary applications will be assessed by academic staff from the University of Bristol School of Veterinary Science. 

Michelle Townley, veterinary advisor at MSD Animal Health (pictured right) said: "New knowledge and good research skills form the lifeblood of the industry so we’re keen to get as many applications as possible as part of our commitment to encouraging research in the veterinary industry."

For further details go to the MSD Animal Health Research Bursary website: www.msdahresearchbursary.co.uk.   

TVM-UK has announced the launch of the 'Corneal Focus Range', a new range of ophthalmology products for dogs, cats, horses and exotics.

The range includes:

• Fluodrop (the first fluorescein product specifically designed for veterinary use)

• Ocryl - an ocular and periocular cleanser that can also be used to reduce and prevent unsightly tear staining

• Ocular lubricants (carbomer and hyaluronic acid based)

• Clerapliq – a novel molecule to the UK veterinary market that is used to help restore and regenerate the corneal extracellular matrix

The products will be supported with a selection of materials to help vets, nurses and pet owners in the maintenance of corneal health, including diagnosis and treatment guidelines, anatomical guides, posters and client educational and treatment aids to help with compliance.

William Peel MRCVS, product manager at TVM-UK said: "Our Corneal Focus Range is an exciting way to expand on our product portfolio following the successful introduction of our ‘Anti-tox’ range.

"With ‘Anti-tox’ we successfully managed to make vets and nurses lives easier by providing education and materials alongside a great range of products to help when dealing with poisoning cases in practice. We also attempted to make clients more aware of the dangers of poisoning in pets.

"We hope to emulate this approach and success with our Corneal Focus Range – by developing a wealth of materials for vets, nurses and clients to aid them in managing and understanding ophthalmology cases – and by providing quality products."

TVM UK will be showcasing its new products and support services at the London Vet Show (stand P40) this November.

For more information, visit: http://www.tvm-uk.com/ 

MSD Animal Health Equine is highlighting the results of a study conducted by the company which, it says, proves that Equilis Prequenza offers highly significant protection against viral shedding and the clinical signs of equine influenza (EI).

Current World Organisation for Animal Health (OIE) recommendations are to include a representative strain from each of the two sublineages of equine influenza virus (EIV) - Florida Clade 1 and Florida Clade 2, to deliver optimum protection. 

MSD's study was designed to evaluate the efficacy of Equilis Prequenza, containing whole virus Newmarket/2/93 (European strain) and South Africa/4/03 (Clade1) EIV strains, and an HA canarypox vectored vaccine containing Florida Clade 1 and Clade 2 strains. 

Two groups of seven Fjord ponies were vaccinated twice, 4 weeks apart (V1 on day 0 and V2 on day 28).  One group was vaccinated with Equilis Prequenza (MSD AH) and one group with ProteqFlu (Boehringer Ingleheim). The protective antibody response was measured and ponies were challenged, along with six unvaccinated control ponies, by experimental infection with Wexford/14 (a heterologous clade 2 strain), 1 20 days (4.5 months) after V2, and clinical signs and virus shedding monitored. EI serology was measured by single radial haemolysis (SRH) and hemagglutination inhibition (HI).  Clinical signs and virus shedding (measured by qRT-PCR and egg titration) were compared between groups and with controls.

Vicki Farr, BVetMed MRCVS, equine veterinary advisor at MSD Animal Health said: "Following challenge at 120 days after V2 with Wexford/14, this study demonstrates that both vaccines provide a highly significant degree of protection against clinical signs of EI and viral shedding compared to unvaccinated controls. Although the study was not designed to compare the efficacy of the two vaccines, because of practical limitations on the number of animals and hence low power, there was no evidence of any significant differences between these two groups. There was, however, a trend towards slightly lower clinical score on days 4-8 and reduced virus excretion on days 2-5 in the Equilis Prequenza group compared to the HA canarypox vectored vaccine.” 

MSD says Equilis Prequenza offers a broad based approach to immunogenicity by addressing and adapting key areas of an equine influenza vaccine - Matrix-C adjuvant, whole virus antigen and strain; efficacy has been proven through challenge trials and longer term protection confirmed by serology.      

Vicki added: "Equilis Prequenza addresses key factors involved in promoting effective immunogenicity. It combines the demonstrated efficacy against challenge, with a current circulating strain with an established safety profile.  Equilis Prequenza stimulates active immunity against EI providing the reassurance your clients demand. MSD Animal Health is committed to working with equine practices to improve vaccination rates in at-risk horses."

For more information about the trial results contact your MSD Animal Health account manager.

The RCVS Disciplinary Committee has decided to suspend overseas-based James Hugh Alexander Crawford MRCVS for a period of 12 months, after he fabricated an email, purporting it to be from a veterinary officer at the Animal Health and Veterinary Laboratories Agency (AHVLA), now known as the Animal and Plant Health Agency.

Dr Crawford sent the email to his client, Mrs X, on 15 July 2014, the day on which Mrs X’s horse was due for insemination using horse semen supplied from a horse in Germany. However, the semen had arrived without the Intra Trade Certificate, a requirement for intra-EU inseminations, and so Dr Crawford proceeded to contact the Department for the Environment, Food and Rural Affairs (Defra) for alternative authorisation.

Just after 4:30pm on that day, Mrs X received a text from Dr Crawford advising her that he had received authorisation from the AHVLA, and would forward to Mrs X the AHVLA authorisation email. It later transpired that that the email had in fact been fabricated by Dr Crawford using an email that he had previously received from the AHVLA regarding another matter.

Dr Crawford faced the following charges:

1. Fabricating an e-mail purporting to be from the veterinary officer at the AVHLA, authorising use of semen from a horse for insemination, when in fact he had not received such authorisation.

2. Dishonesty in relation to the e-mail described above.

3. His conduct gave rise to spread of infectious disease which had the potential to affect equine animal health and welfare in the region.

Dr Crawford admitted the first two charges, but denied that his actions had given rise to the risk of disease.

The Committee found the first two charges proved, and moved on to determine the facts of the third charge. They took into account that Dr Crawford had received verbal confirmation that the semen was safe, and that the health papers had been stamped accordingly. He had not, however, seen a copy of this certificate and so there was no guarantee that the semen was safe to use at the time he sent the fabricated email. On consideration of the facts, the Committee found this charge proved, as Mrs X’s mare could have been infected and subsequently could have adversely affected equine animal health and welfare in the region.

They also found that his entire course of action had fallen far short of what is expected of a veterinary surgeon, and that it amounted to disgraceful conduct in a professional respect. 

When determining sanction, the Committee took into account a number of aggravating factors, namely the risk of injury to animals, an element of pre-meditation, a disregard for the role of the AHVLA, impersonating a fellow veterinary surgeon, and intending to deceive a veterinary surgeon as well as a member of the public.

It did also, however, take into account the mitigating factors – that there was no injury to the animal, and that it was a single isolated incident from which Dr Crawford did not stand to make any financial gain.

The Committee therefore decided to order the Registrar to suspend Dr Crawford’s registration for 12 months.

Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee did consider whether to remove Dr Crawford from the Register. However, in light of the significant mitigation in this case, the fact that this was an isolated incident in an otherwise unblemished career, together with his acceptance from the outset that he had been dishonest and his assurance that he would never behave in this way again, the Committee decided that in all the circumstances to remove him from the Register would be disproportionate."

Dr Crawford can lodge an appeal with the Privy Council within 28 days of being notified of the Disciplinary Committee's decision.

The RCVS Disciplinary Committee has found Cheshire-based Paul Stuart Thomason MRCVS not guilty of disgraceful conduct after hearing charges that he undertook a pre-purchase examination of a horse called Reba which caused him to have a potential or actual conflict of interest with the seller, about which he failed to inform the prospective buyer.

Dr Thomason initially denied both heads of charge, but on the third day of the hearing he changed his plea and admitted the charge in its entirety.

The first part of the charge related to the fact that the seller of the horse was a both a client of Dr Thomason’s practice and a personal friend of his, and he therefore had a potential and/or actual conflict of interest.

Dr Thomason did not disclose this professional and personal relationship to the prospective purchaser before the pre-purchase exam.

The prospective purchaser only discovered Dr Thomason’s relationship with the seller when reading the vetting certificate at home, and stated that, in the past, she had had a similar experience in which the horse was then found to be lame. She later found out the extent of the personal relationship, when invited to join the seller on a social media site.

The Committee found that, in this set of circumstances, Dr Thomason should not have undertaken the pre-purchase exam at all, and, at the very least, disclosed his personal and professional relationship with the vendor.

The Committee also found that although Dr Thomason did have a system in place to inform any prospective purchasers if the vendor was a client of his practice, this failed to work on this occasion and neither the practice nor Dr Thomason told the prospective buyer that the seller was a client before booking the pre-purchase exam. Dr Thomason had no similar system in place to disclose any close friendships with sellers.

Dr Thomason did not consider there was a conflict of interest as he felt confident he could carry out the pre-purchase exam impartially. In addition, it was his belief that the seller had been alerted to the conflict through a system in place at his practice, implemented to safeguard against this type of error. He stated that he in no way attempted to hide his relationship with the seller to the prospective purchaser. 

It was not alleged that Dr Thomason had acted dishonestly.

Ultimately, the Committee found Dr Thomason not guilty of disgraceful conduct in a professional respect.

Ian Green, chairing the Committee and speaking on its behalf, said: "Whilst the Committee concluded that the respondent’s view of his obligations to disclose both the professional and personal relationships he had with the vendor was mistaken, it did not find any improper motivation on his part. It has already noted that he sought to disclose to the prospective purchaser through his system the fact that the vendor was a professional client of his.

"The Committee has weighed all these matters very carefully. It is for the client to determine whether or not to proceed with a PPE when in possession of all relevant facts in relation to any potential conflict of interest, and not for the veterinary surgeon to decide. The autonomy of the client must be respected. The Committee was firmly of the opinion that a failure to comply with the Code is very serious. However, taking into account the particulars of this case, the Committee does not consider that the actions of the respondent amount to disgraceful conduct in a professional respect."

Boehringer Ingelheim has rebranded its equine joint supplement, Seraquin GLME, as Equitop GLME.

Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments. It is derived from an active extract of New Zealand Green Lip Mussels - a natural source of glucosaminoglycans (GAGs), chondroitin and essential fatty acids – and is tested free of prohibited substances.

Boehringer says the nutrients in Equitop GLME help to lubricate joints, as well as supporting normal joint function, the stability and elasticity of ligaments and the shock-absorbing properties of cartilage.

Equitop GLME is fed once a day either separately or mixed with feed and one tub will typically last for 30 days and can be used in all horses and ponies.

Dr Amy Scott, brand manager for Equitop GLME at Boehringer Ingelheim, said: "By encompassing Equitop GLME into the Equitop portfolio and launching easy-to-read new packaging, we are enhancing our product offering to both veterinary practices and horse owners."

For more information, contact your Boehringer account manager.

His Royal Highness The Prince of Wales has visited Pool House Equine Clinic to mark the opening of its new, purpose-built facility in Fradley, near Lichfield.

This multimillion pound centre will support the provision of advanced first opinion and referral equine services in the Midlands. 

Senior Partner Richard Stephenson said: "It was a great honour and pleasure to have His Royal Highness visit our new premises, and our staff eagerly anticipated meeting Prince Charles and showing him the wonderful facilities we now have."

Amongst these are a Fujifilm SonoSite Edge II portable ultrasound system. Richard added: "Pool House is a well-known practice – we’ve been in existence for over 150 years – and we have developed a reputation as a specialist equine imaging centre, with radiography, ultrasound and MRI capabilities. The new facility has been designed to give us increased theatre capacity and stabling, and we needed an additional ultrasound system to match this expansion."

"The demands of equine practice mean that ultrasound is often required in difficult circumstances, and we need systems that can cope with extreme temperatures, dust, straw, mud, water and the occasional knock. Many pieces of equipment used in veterinary medicine were originally intended for a human clinical environment, so can’t stand up to the rigors of our work – they’re simply not fit for purpose. However, SonoSite systems are perfect for us; they’re robust, highly portable and very intuitive to use, which is important for intermittent ultrasound users."

Boehringer Ingelheim, manufacturer of Prascend, has launched www.careaboutcushings.co.uk, an information resource for horse owners.

The Care About Cushing’s website is designed to give horse owners the information they need to spot the signs of Cushing's, thereby prompting diagnosis by their veterinary surgeon.

The online resource includes monitoring tools, personalised alerts, owner guides and webinars. It also offers downloadable self-assessment checklists on Cushing’s disease and laminitis to take owners through the signs to look out for.

Owners whose horses have been diagnosed with Cushing’s are encouraged to sign up as a Care About Cushing’s member to keep up-to-date with the latest information about the disease and create a personal profile for their horse in order to monitor progress. One of the membership benefits is an 'ask the expert' section where members can ask questions about Cushing’s disease and laminitis.

The Care About Cushing’s resource supports Boehringer’s ‘Talk About Laminitis’ initiative to raise awareness of the signs of laminitis and its link with Cushing’s disease.

Talk About Laminitis now runs throughout the year and as part of the campaign the laboratory fees for the blood test which detects Cushing’s (the basal ACTH test) are free. 

Liz Barrett, equine business head at Boehringer, said: "Our Talk About Laminitis disease awareness initiative has been hugely successful in highlighting the link between laminitis and Cushing’s disease and helping to diagnose Cushing’s. So much so that Cushing’s is now in the top five equine diseases recorded in the UK¹."

For further information on Talk About Laminitis or Care About Cushing’s, visit www.talkaboutlaminitis.co.uk, www.careaboutcushings.co.uk or contact your local Boehringer territory manager.

Reference

1. National Equine Health Survey (NEHS) 2017

Defra has announced that the law which requires horses born since July 2009 to be microchipped is being extended to include all horses, ponies and donkeys, regardless of their age.

From October 2020 it will be mandatory for all owners to microchip their horses, ponies and donkeys, or face a fine of up to £200. The new Central Equine Database will then allow local authorities and police to track down the owners of dumped horses and make sure they are punished. It will also mean lost or stolen horses will be reunited with their owners more easily.

Lord Gardiner, Animal Welfare Minister, said: "The government shares the British public’s high regard for animal welfare and it is completely unacceptable that hundreds of horses and ponies are left abandoned every year by irresponsible owners.

"That is why we have today laid new regulations in Parliament requiring horses to be microchipped. This will bolster the ability of local authorities and police to identify abandoned animals, ensuring these beautiful creatures receive the care they deserve and that those who mistreat them will face the consequences."

The BVA has welcomed the move as an important step forward for horse welfare and the integrity of the UK food chain.

British Veterinary Association Senior Vice President Gudrun Ravetz said: "We welcome this announcement to extend compulsory microchipping and believe that the measures represent an important step forward for horse welfare and the integrity of the UK food chain. The one-off cost of microchipping a horse is minimal while the animal welfare benefits in terms of being able to identify lost, stolen, abandoned or fly grazing horses, and identify horses in the face of disease outbreak, as well as the benefits to the integrity of food chain safety, are enormous. 

"Universal microchipping of domesticated horses ensures that the legislation has value, the cost of implementing the new Central  Equine Database (CED) is not wasted, and that food safety is protected. Together these measures will protect horses, ponies and donkeys from irresponsible owners, help loving owners to be reunited with their animals and keep the food chain free from potentially contaminated horse meat."

The regulations for the database were laid in Parliament today and, subject to parliamentary approval, will come into force on 1 October 2018.